Is EYEG stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, EyeGate Pharmaceuticals pays dividends. Last time was Tuesday 6th of August 2024 where the investors holding the stock on Thursday 1st of August 2024 were paid $0.15460 per share. Over the last 8 times between 2023 and 2024, EyeGate Pharmaceuticals has paid $1.1515 with an average of $0.14 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for EyeGate Pharmaceuticals 10 years ago, but if you had invested on Friday 31st of July 2015 when the price was $7.15, you would have made a profit of $29.66 per share or 414.83%
No, the average daily trading liquidity for EyeGate Pharmaceuticals is $25 542 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
EyeGate Pharmaceuticals has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for EyeGate Pharmaceuticals to be medium [0.7 out of 1]